i-Base home
Search Menu
  • Home
  • HTB
  • CROI 31 Denver 2024

CROI 31 Denver 2024

Doxy-PEP studies at CROI 2024

9 June 2024. Related: Conference reports, Coinfections and complications.

HIV and statins: REPRIEVE studies at CROI 2024

6 June 2024. Related: Conference reports, Weight, diabetes, metabolic complications.

Challenges with annual TAF implant

5 June 2024. Related: Conference reports, Antiretrovirals.

CROI 2024 now online and open access

10 April 2024. Related: Conference reports.

BHIVA best of CROI webinars now online

4 April 2024. Related: Conference reports.

CROI 2024: Opening lecture calls for scientists to speak up for LGBTQ+ rights in Uganda

24 March 2024. Related: Conference reports, Treatment access, Women's health, Pregnancy, Vaccines and microbicides.

CROI 2024: Pipeline ART – new drugs and formulations

19 March 2024. Related: Conference reports, Antiretrovirals.

CROI 2024: Studies using tecovirimat to treat mpox

16 March 2024. Related: Conference reports, mpox.

CROI 2024: Promising results from first study of long-acting treatment in Africa

10 March 2024. Related: Conference reports, Antiretrovirals, Treatment access.

CROI 2024: HIV studies with semaglutide: significant benefits but limited access for treatment and research

10 March 2024. Related: Conference reports, Weight, diabetes, metabolic complications.

CROI 2024: studies to watch for at this upcoming conference

1 March 2024. Related: Conference reports.

  • HTB RSS

Early access

  • Vaccination effectively limits mpox progression: lower efficacy in people living with HIV 27 May 2025
  • US update guidelines for statin use in people living with HIV 26 May 2025
  • HIV activists in the US call for action and Zachie Achmet brings South African perspective 26 May 2025
  • Scientific, legal and ethical crisis from halting ongoing NIH studies: TAG statement 22 May 2025
  • All early access reports

Current issues

  • May 2025
  • April 2025
  • March 2025
  • Back issues

Special report

  • Scientific, legal and ethical crisis from halting ongoing NIH studies: TAG statement 22 May 2025

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage
  • Donate

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
Registered charity number: 1081905. Company number: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Donate
Feedback
Advice and information
Q and A
Guides
HIV meds
Glossary
Research reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
News and updates
Sitemap
Home
Find us on Facebook
i-Base on Facebook